Neurocognition and Work Productivity in Major Depressive Disorder.

Trial Profile

Neurocognition and Work Productivity in Major Depressive Disorder.

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Apr 2015

At a glance

  • Drugs Desvenlafaxine (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 31 Jul 2013 Planned end date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
    • 25 Jan 2012 Actual initiation date (January 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top